Live Breaking News & Updates on மெர்க் ப்ரைவேட்

Stay updated with breaking news from மெர்க் ப்ரைவேட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Merck Inks Deal With U.S. Government To Supply 1.7 Mln Courses Of Molnupiravir


Merck Inks Deal With U.S. Government To Supply 1.7 Mln Courses Of Molnupiravir
KENILWORTH (NJ) (dpa-AFX) - Merck & Co Inc. (MRK), known as MSD outside the U. S. and Canada, today announced it has entered into a procurement agreement with the U.S. government for molnupiravir (MK-4482). Merck is developing molnupiravir in collaboration with Ridgeback Biotherapeutics.
Through the agreement, if molnupiravir receives Emergency Use Authorization (EUA) or approval by the U.S. Food and Drug Administration (FDA), Merck will receive approximately $1.2 billion to supply approximately 1.7 million courses of molnupiravir to the U.S. government.
Molnupiravir is currently being evaluated in a Phase 3 clinical trial, the MOVe-OUT study, for the treatment of non-hospitalized patients with laboratory-confirmed COVID-19 and at least one risk factor associated with poor disease outcomes. ....

Ridgeback Biotherapeutics , Merck Co Inc , Drug Administration , World Bank , Emergency Use Authorization , மெர்க் இணை இன்க் , உலகம் வங்கி , அவசரம் பயன்பாடு அங்கீகாரம் ,

Merck investigating after noose found at Durham vaccine plant

The incident happened at the pharmaceutical company’s Durham site, which was tapped earlier this year to help manufacture Johnson & Johnson COVID-19 vaccines. ....

Sabeacony Sabeacon , Pharmaceutical Company , North Durham , Patrick Ryan , Site Management ,